Skip to main content
Log in

GlaxoSmithKline strikes back over anti-ageing pills

  • News
  • Published:

From Nature

View current issue Submit your manuscript

Drugs do work as thought, says pharmaceutical giant.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Dai, J. et al. J. Biol. Chem. advance online publication doi:10.1074/jbc.M110.133892 (2010)

  2. Kaeberlein, M. et al. J. Biol. Chem. 280, 17038-17045 (2005).

    Article  Google Scholar 

  3. Beher, D. et al. Chem. Biol. Drug. Des. 74, 619-624 (2009).

    Article  Google Scholar 

  4. Pacholec, M. et al. J. Biol. Chem. 285, 8340-8351 (2010).

    Article  Google Scholar 

  5. Baur, J. et al. Nature 444, 337-342 (2006).

    Article  ADS  Google Scholar 

  6. Milne, J. C. et al. Nature 450, 712-716 (2007).

    Article  ADS  Google Scholar 

Download references

Authors

Related links

Related links

Related external links

Sirtris Pharmaceuticals

Ronen Marmorstein

Joseph Bauer

Matt Kaeberlein

Healthy Lifespan Institute

Rights and permissions

Reprints and permissions

About this article

Cite this article

Callaway, E. GlaxoSmithKline strikes back over anti-ageing pills. Nature (2010). https://doi.org/10.1038/news.2010.412

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/news.2010.412

  • Springer Nature Limited

Navigation